Advertisement

Author: Janine Anthes

September 2019 Briefing – Cardiology

Here are what the editors at HealthDay consider to be the most important developments in Cardiology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Panel Votes Yes to Current Level of Red, […]

Read More

September 2019 Briefing – Dermatology

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Heart Disease May Up Risk for Allopurinol-Linked Cutaneous […]

Read More

September 2019 Briefing – Diabetes & Endocrinology

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Panel Votes Yes to Current Level […]

Read More

September 2019 Briefing – Family Practice

Here are what the editors at HealthDay consider to be the most important developments in Family Practice for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Panel Votes Yes to Current Level of […]

Read More

September 2019 Briefing – Gastroenterology

Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. CVS Halts Sales of OTC Zantac MONDAY, Sept. […]

Read More

September 2019 Briefing – HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Average Annual Premium for Workers Increased […]

Read More

September 2019 Briefing – Infectious Disease

Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. CDC Says People Can Contract Tuberculosis From […]

Read More

September 2019 Briefing – Neurology

Here are what the editors at HealthDay consider to be the most important developments in Neurology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Recommendations Updated for Management of Pediatric ADHD MONDAY, […]

Read More

September 2019 Briefing – Nursing

Here are what the editors at HealthDay consider to be the most important developments in Nursing for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Panel Votes Yes to Current Level of Red, […]

Read More

September 2019 Briefing – OBGYN & Women’s Health

Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Panel Votes Yes to Current […]

Read More

September 2019 Briefing – Ophthalmology

Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Infectious Disease Consultation May Lower Candida Mortality FRIDAY, […]

Read More

September 2019 Briefing – Orthopedics

Here are what the editors at HealthDay consider to be the most important developments in Orthopedics for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Sports Specialization Ups Injury Risk, Especially in Girls […]

Read More

September 2019 Briefing – Psychiatry

Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Most Severe Forms of Mental Illness Lead to […]

Read More

September 2019 Briefing – Surgery

Here are what the editors at HealthDay consider to be the most important developments in Surgery for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Adverse Outcomes Up for Vaginal Birth After Previous […]

Read More

September 2019 Briefing – Urology

Here are what the editors at HealthDay consider to be the most important developments in Urology for September 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. SBRT Shortens Tx for Prostate Cancer Without Greater […]

Read More

For latest news and updates
Email-id is invalid